speb/financial-data huggingface dataset:
Financial ratios for SCHAEFFLER.NS — quarterly report dated 2025-03-31
Total revenue: 254198036.00654662
Gross profit: 96620294.599018
Operating income: 36209960.25251344
Net income: 29415478.13888239
Capital expenditures: 0
Depreciation & amortization: 9714753.331774607
Owner earnings: 39130231.470657
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 38.75294666822266
P/E ratio: 51.47993650620642
Shares outstanding: 156303670
Market cap (USD): 6057227787.557474
Effective tax rate (%): 26.36877066690077
Interest coverage ratio: 198.55128205128204
COGS to revenue (%): 61.990149051926736
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 2.092869624456405
Rule of 40 score: 2.092869624456405
Financial ratios for SCHAEFFLER.NS — quarterly report dated 2025-06-30
Total revenue: 275285513.69061553
Gross profit: 108132459.63023637
Operating income: 40884624.38567752
Net income: 33595834.3084484
Capital expenditures: 0
Depreciation & amortization: 9445354.551837118
Net tangible assets: 618824011.2333256
Owner earnings: 43041188.86028551
Return on net tangible assets (%): 6.955319780579259
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 46.97250175520712
P/E ratio: 80.97508592310132
Shares outstanding: 156303670
Book value: 635954832.6702552
P/B ratio: 11.544804813563157
Market cap (USD): 7341974413.420315
Debt to equity: 0.010117997302603373
Current ratio: 2.551734770853867
Quick ratio: 1.6688324917817947
Effective tax rate (%): 26.636003577360423
Interest coverage ratio: 323.51851851851853
COGS to revenue (%): 60.71988744320089
Buyback yield (%): 0
Inventory turnover: 0.8908963908620894
Receivables turnover: 1.5712844968074593
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.3608228654651375
Revenue growth (%): 8.29568867460716
Rule of 40 score: 8.29568867460716
Financial ratios for SCHAEFFLER.NS — quarterly report dated 2025-12-31
Total revenue: 303464409.0453381
Gross profit: 117962571.01481564
Operating income: 43678288.96067729
Net income: 35909546.6191378
Capital expenditures: 0
Depreciation & amortization: 10250640.525788127
Net tangible assets: 657962571.0148157
Owner earnings: 46160187.14492593
Return on net tangible assets (%): 7.0156250793613175
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 42.85774757714159
P/E ratio: 52.9220348092125
Shares outstanding: 156303670
Book value: 673717277.4869109
P/B ratio: 9.943077694591235
Market cap (USD): 6698823234.240838
Debt to equity: 0.009039411636320348
Current ratio: 2.592064011534977
Quick ratio: 1.7517228949377954
Effective tax rate (%): 25.689257722452748
Interest coverage ratio: 243.54037267080747
COGS to revenue (%): 61.12803758901696
Buyback yield (%): 0
Retained earnings: 609678066.1690989
Inventory turnover: 0.9398899393255256
Receivables turnover: 1.643787674911149
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.423330400978982
Revenue growth (%): 10.236243446646418
Rule of 40 score: 10.236243446646418
Financial ratios for SCHAEFFLER.NS — annual report dated 2025-12-31
Total revenue: 1063830901.191935
Gross profit: 361433663.8075081
Operating income: 158469421.85585386
Net income: 128144146.15127549
Capital expenditures: 51532806.059930936
Operating cash flow: 143703909.9922023
Depreciation & amortization: 38288960.6772864
Net tangible assets: 657962571.0148157
Owner earnings: 114900300.76863097
Return on net tangible assets (%): 17.463045138177577
Capex to operating income (%): 32.519085042668955
Buffett classification: The Good
Stock price: 42.85774757714159
P/E ratio: 52.27568668125353
Shares outstanding: 156303670
Book value: 673717277.4869109
P/B ratio: 9.943077694591235
Market cap (USD): 6698823234.240838
Debt to equity: 0.009039411636320348
Current ratio: 2.592064011534977
Quick ratio: 1.7517228949377954
Effective tax rate (%): 26.37100284185463
Interest coverage ratio: 360.14683544303796
COGS to revenue (%): 66.02527117772652
SG&A to revenue (%): 1.9350765077732903
Free cash flow (dilution-adjusted): 92035201.06939958
Buyback yield (%): 0
Retained earnings: 609678066.1690989
Inventory turnover: 3.558865528432341
Receivables turnover: 5.762494946508414
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.304517627708947
FCF margin (%): 8.651299841570847
Revenue growth (%): 12.471551875394942
Rule of 40 score: 21.12285171696579
Financial ratios for STS.V — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 1.2992125984251968
Shares outstanding: 140425944
Market cap (USD): 182443155.59055117
Buyback yield (%): 0
Capitalized R&D asset: 58488.50393700787
Rule of 40 score: 0
Financial ratios for STS.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -7963.522058823529
Operating income: -2361329.4485294116
Net income: -2656033.830882353
Capital expenditures: 633250.6617647059
Operating cash flow: 5229804.330882353
Depreciation & amortization: 7963.522058823529
Net tangible assets: 6034380.147058823
Owner earnings: -3281320.970588235
Return on net tangible assets (%): -54.377100723221126
Buffett classification: The Gruesome
Stock price: 0.40441176470588236
Shares outstanding: 140425944
Book value: 6034380.147058824
P/B ratio: 9.411058375433804
Market cap (USD): 56789903.823529415
Debt to equity: 0.0024520038792424335
Current ratio: 15.85929180947354
Quick ratio: 15.85929180947354
Interest coverage ratio: -5.67620228199233
Free cash flow (dilution-adjusted): 4422735.610294118
Buyback yield (%): 0
Retained earnings: -16840900
Receivables turnover: 0
Capitalized R&D asset: 74919.38587308938
ROCI (R&D-adjusted, %): -17.01875202996087
Rule of 40 score: 0
Financial ratios for STS.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -23617.42424242424
Operating income: -2381125.7575757573
Net income: -2816195.4545454546
Capital expenditures: 6952840.151515151
Operating cash flow: -1755056.8181818181
Depreciation & amortization: 23617.42424242424
Net tangible assets: 6897718.181818182
Owner earnings: -9745418.181818182
Return on net tangible assets (%): -141.28466726150546
Buffett classification: The Gruesome
Stock price: 0.5681818181818181
Shares outstanding: 140425944
Book value: 6897718.181818182
P/B ratio: 11.567226447744906
Market cap (USD): 79787468.18181817
Debt to equity: 0.0008582109059341978
Current ratio: 2.3570857335530535
Quick ratio: 2.3570857335530535
Interest coverage ratio: -1646.4567836563645
Free cash flow (dilution-adjusted): -8837328.03030303
Buyback yield (%): 0
Retained earnings: -20167425.757575758
Receivables turnover: 0
Capitalized R&D asset: 92281.09935625359
ROCI (R&D-adjusted, %): -15.61898517637772
Rosenberg metric: -0.438090885719315
Rule of 40 score: 0
Financial ratios for STS.V — quarterly report dated 2024-09-30
Capital expenditures: 1405222.222222222
Depreciation & amortization: 2514.814814814815
Buffett classification: The Gruesome
Stock price: 0.4444444444444444
Shares outstanding: 140425944
Market cap (USD): 62411530.666666664
Buyback yield (%): 0
Capitalized R&D asset: 38781.48148148148
Rule of 40 score: 0
Financial ratios for STS.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -14470.62937062937
Operating income: -3721854.5454545454
Net income: -3919428.6713286713
Capital expenditures: 2683327.272727273
Operating cash flow: -3852904.195804196
Depreciation & amortization: 14470.62937062937
Net tangible assets: 2951278.321678322
Owner earnings: -6588285.314685315
Return on net tangible assets (%): -223.2349713102868
Buffett classification: The Gruesome
Stock price: 0.38461538461538464
Shares outstanding: 140425944
Book value: 2951278.321678322
P/B ratio: 18.300537114650805
Market cap (USD): 54009978.461538464
Debt to equity: 0
Current ratio: 0.5750095830928209
Quick ratio: 0.5058461354775523
Interest coverage ratio: -26217.990147783246
Free cash flow (dilution-adjusted): -6687385.314685315
Buyback yield (%): 0
Retained earnings: -22535513.986013986
Inventory turnover: 0.0671466953948393
Receivables turnover: 0
Capitalized R&D asset: 119700.43060948855
ROCI (R&D-adjusted, %): -33.23310556280638
Rosenberg metric: 0.18651932940074814
Rule of 40 score: 0
Financial ratios for STS.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 1731.79020979021
Buffett classification: The Gruesome
Stock price: 0.38461538461538464
Shares outstanding: 140425944
Market cap (USD): 54009978.461538464
Buyback yield (%): 0
Capitalized R&D asset: 48549.66951566952
Rule of 40 score: 0
Financial ratios for STS.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -2479.72027972028
Operating income: -1240857.3426573428
Net income: -482913.2867132867
Capital expenditures: 53734.26573426573
Operating cash flow: -1057816.7832167833
Depreciation & amortization: 2479.72027972028
Net tangible assets: 4169827.272727273
Owner earnings: -534167.8321678322
Return on net tangible assets (%): -12.810310769022815
Buffett classification: The Gruesome
Stock price: 0.3216783216783217
Shares outstanding: 140425944
Book value: 4169827.2727272734
P/B ratio: 10.833058309503857
Market cap (USD): 45171981.98601399
Debt to equity: 0
Current ratio: 0.5489008314222046
Quick ratio: 0.3843975049705356
Free cash flow (dilution-adjusted): -1430098.6013986017
Buyback yield (%): 0
Retained earnings: -23018427.272727273
Inventory turnover: 0.006090313893335349
Receivables turnover: 0
Capitalized R&D asset: 40172.40518259518
ROCI (R&D-adjusted, %): -10.327933948212602
Rule of 40 score: 0
Financial ratios for STS.V — quarterly report dated 2025-06-30
Total revenue: 16597.810218978102
Gross profit: -2712.4087591240873
Operating income: -959790.510948905
Net income: -206513.86861313868
Capital expenditures: 181762.77372262772
Operating cash flow: -716089.7810218978
Depreciation & amortization: 2712.4087591240873
Net tangible assets: 4754642.335766423
Owner earnings: -385564.23357664235
Return on net tangible assets (%): -8.109216347910458
Buffett classification: The Gruesome
Stock price: 0.1678832116788321
Shares outstanding: 140425944
Book value: 4754642.3357664235
P/B ratio: 4.958345300635874
Market cap (USD): 23575158.481751822
Debt to equity: 0
Current ratio: 0.31100701999748803
Quick ratio: 0.07118058502242124
Interest coverage ratio: -6.912772389138607
COGS to revenue (%): 116.34196754474691
R&D to revenue (%): 79.61212014600466
SG&A to revenue (%): 1731.6636615506397
Free cash flow (dilution-adjusted): -955754.7445255474
Buyback yield (%): 0
Retained earnings: -24233047.445255473
Inventory turnover: 0.04680660582663067
Receivables turnover: 0.8684642707100027
Capitalized R&D asset: 28871.687983768057
ROCI (R&D-adjusted, %): -7.196314771532563
Rosenberg metric: -0.018986848818684423
FCF margin (%): -5758.318307753199
Rule of 40 score: -5758.318307753199
Financial ratios for STS.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -2802.877697841727
Operating income: -949115.8273381295
Net income: -763483.4532374102
Capital expenditures: 88456.11510791368
Operating cash flow: -395521.582733813
Depreciation & amortization: 2802.877697841727
Net tangible assets: 4312938.848920864
Owner earnings: -849136.6906474822
Return on net tangible assets (%): -19.688122655853185
Buffett classification: The Gruesome
Stock price: 0.10071942446043167
Shares outstanding: 140425944
Book value: 4312938.848920863
P/B ratio: 3.2793463469883584
Market cap (USD): 14143620.258992808
Debt to equity: 0.11239244134889413
Current ratio: 0.2836175156256959
Quick ratio: 0.051129615333224486
Interest coverage ratio: -113.77930142302715
Free cash flow (dilution-adjusted): -429768.345323741
Buyback yield (%): 0
Retained earnings: -24672396.4028777
Inventory turnover: 0.007774740077028996
Receivables turnover: 0
Capitalized R&D asset: 21008.314106940164
ROCI (R&D-adjusted, %): -6.9651090883122295
Rosenberg metric: -0.0068465141713067515
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for STS.V — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -2894.890510948905
Operating income: -863398.5401459853
Net income: 500867.1532846715
Capital expenditures: 78194.1605839416
Operating cash flow: -1309577.3722627736
Depreciation & amortization: 2894.890510948905
Net tangible assets: 4714855.474452554
Owner earnings: 425567.88321167877
Return on net tangible assets (%): 9.026106643514705
Buffett classification: The Gruesome
Stock price: 0.10218978102189781
P/E ratio: 7.162626044174483
Shares outstanding: 140425944
Book value: 4714855.474452555
P/B ratio: 3.0435920135642087
Market cap (USD): 14350096.467153285
Debt to equity: 0.0324506235300383
Current ratio: 0.7512149937920025
Quick ratio: 0.6826614572042332
Interest coverage ratio: -81.20664561307153
Free cash flow (dilution-adjusted): -1275290.510948905
Buyback yield (%): 0
Retained earnings: -24531710.2189781
Inventory turnover: 0.014251935115244469
Receivables turnover: 0
Capitalized R&D asset: 9794.806858163105
ROCI (R&D-adjusted, %): -6.356881886350325
Rosenberg metric: -0.011344492657351237
Rule of 40 score: 0
Financial ratios for STS.V — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -11039.41605839416
Operating income: -4047980.2919708025
Net income: -1009239.4160583941
Capital expenditures: 249403.64963503648
Operating cash flow: -3531107.2992700725
Depreciation & amortization: 11039.41605839416
Net tangible assets: 4714855.474452554
Owner earnings: -1247603.6496350365
Return on net tangible assets (%): -26.46112179673751
Buffett classification: The Gruesome
Stock price: 0.10218978102189781
Shares outstanding: 140425944
Book value: 4714855.474452555
P/B ratio: 3.0435920135642087
Market cap (USD): 14350096.467153285
Debt to equity: 0.0324506235300383
Current ratio: 0.7512149937920025
Quick ratio: 0.6826614572042332
Interest coverage ratio: -211.98474828943844
Free cash flow (dilution-adjusted): -4159818.248175182
Buyback yield (%): 0
Retained earnings: -24531710.2189781
Inventory turnover: 0.054348529168673054
Receivables turnover: 0
Capitalized R&D asset: 66468.13986013987
ROCI (R&D-adjusted, %): -29.73938710171971
Rosenberg metric: 0.045717540521745655
Rule of 40 score: 0
Financial ratios for TIE.V — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.2890625
Shares outstanding: 7295642
Market cap (USD): 9404538.515625
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TIE.V — annual report dated 2022-09-30
Total revenue: 44525.54744525547
Gross profit: -191240.87591240875
Operating income: -1011678.8321167883
Net income: -381021.897810219
Capital expenditures: 65693.4306569343
Operating cash flow: -7462043.795620438
Depreciation & amortization: 0
Net tangible assets: 15409489.05109489
Owner earnings: -446715.32846715325
Return on net tangible assets (%): -2.8989626261190846
Buffett classification: The Gruesome
Stock price: 0.7007299270072992
Shares outstanding: 7295642
Book value: 15490510.948905108
P/B ratio: 0.3300262143059089
Market cap (USD): 5112274.686131386
Debt to equity: 0
Current ratio: 57.65415549597855
Quick ratio: 57.65415549597855
COGS to revenue (%): 529.5081967213116
SG&A to revenue (%): 1842.622950819672
Free cash flow (dilution-adjusted): -7834306.569343065
Buyback yield (%): 5.368501725642058
Retained earnings: -165413868.61313868
Receivables turnover: 0.07973856209150326
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.530958439355386
FCF margin (%): -17595.081967213115
Rule of 40 score: -17595.081967213115
Financial ratios for TIE.V — annual report dated 2023-09-30
Total revenue: 5060000
Gross profit: 4794074.074074074
Operating income: 2865925.925925926
Net income: 2522962.9629629627
Capital expenditures: 0
Operating cash flow: 2494074.0740740737
Depreciation & amortization: 6666.666666666666
Net tangible assets: 14353333.333333332
Owner earnings: 2529629.629629629
Return on net tangible assets (%): 17.623987201321153
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.9777777777777776
P/E ratio: 5.719132160892543
Shares outstanding: 7295642
Book value: 14353333.333333332
P/B ratio: 1.0052827651339218
Market cap (USD): 14429158.62222222
Debt to equity: 0
Current ratio: 6.238442822384428
Quick ratio: 6.238442822384428
COGS to revenue (%): 5.255453081540037
R&D to revenue (%): 0
SG&A to revenue (%): 44.86897965158835
Free cash flow (dilution-adjusted): 1841481.481481481
Buyback yield (%): 32.742341865785356
Retained earnings: -118530370.37037036
Receivables turnover: 7.878892733564015
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.96697115136502
FCF margin (%): 36.39291465378422
Revenue growth (%): 11264.262295081968
Rule of 40 score: 11300.655209735753
Financial ratios for TIE.V — annual report dated 2024-09-30
Total revenue: -611851.8518518518
Gross profit: -878518.5185185184
Operating income: 119259.25925925926
Net income: 1078518.5185185184
Capital expenditures: 0
Operating cash flow: -141481.48148148146
Depreciation & amortization: 15555.555555555555
Net tangible assets: 15788148.148148147
Owner earnings: 1094074.074074074
Return on net tangible assets (%): 6.92971755653561
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.6666666666666666
P/E ratio: 4.50966881868132
Shares outstanding: 7295642
Book value: 15788148.148148147
P/B ratio: 0.3080640799474524
Market cap (USD): 4863761.333333333
Debt to equity: 0
Current ratio: 10.89967487227125
Quick ratio: 10.89967487227125
Free cash flow (dilution-adjusted): -474814.8148148148
Buyback yield (%): 0
Retained earnings: -117451851.85185185
Receivables turnover: -2.070175438596491
Capitalized R&D asset: 19259.25925925926
ROCI (R&D-adjusted, %): 0.8356763511402687
Revenue growth (%): -112.09193383106427
Rule of 40 score: -112.09193383106427
Financial ratios for TIE.V — quarterly report dated 2024-09-30
Total revenue: 88888.88888888888
Gross profit: 338518.5185185185
Capital expenditures: 0
Depreciation & amortization: 15555.555555555555
Buffett classification: The Gruesome
Stock price: 0.6666666666666666
Shares outstanding: 7295642
Market cap (USD): 4863761.333333333
COGS to revenue (%): -280.83333333333337
R&D to revenue (%): 6.666666666666667
Buyback yield (%): 0
Retained earnings: -117451851.85185185
Receivables turnover: 0.30075187969924805
Capitalized R&D asset: 5925.925925925925
Rule of 40 score: 0
Financial ratios for TIE.V — quarterly report dated 2024-12-31
Total revenue: -25174.825174825175
Operating income: -7420279.720279721
Net income: -7497202.797202798
Capital expenditures: 0
Operating cash flow: 18881.11888111888
Net tangible assets: 7407692.307692308
Owner earnings: -7497202.797202798
Return on net tangible assets (%): -101.20834513357877
Buffett classification: The Gruesome
Stock price: 0.4405594405594406
Shares outstanding: 7295642
Book value: 7407692.307692308
P/B ratio: 0.4338954460492778
Market cap (USD): 3214163.958041958
Debt to equity: 0
Current ratio: 6.457496136012365
Quick ratio: 6.457496136012365
Free cash flow (dilution-adjusted): 18881.11888111888
Buyback yield (%): 0
Retained earnings: -118378321.67832169
Receivables turnover: -0.09022556390977443
Capitalized R&D asset: 10264.076664076663
ROCI (R&D-adjusted, %): -100.00138637064143
Revenue growth (%): -128.32167832167835
Rule of 40 score: -128.32167832167835
Financial ratios for TIE.V — quarterly report dated 2025-03-31
Total revenue: -504195.80419580423
Operating income: -1504195.8041958043
Net income: -1416783.216783217
Capital expenditures: 0
Operating cash flow: 423776.2237762238
Net tangible assets: 5990909.090909091
Owner earnings: -1416783.216783217
Return on net tangible assets (%): -23.648885257382986
Buffett classification: The Gruesome
Stock price: 0.4405594405594406
Shares outstanding: 7295642
Book value: 5990909.090909091
P/B ratio: 0.5365068822224817
Market cap (USD): 3214163.958041958
Debt to equity: 0
Current ratio: 5.279162512462612
Quick ratio: 5.279162512462612
Free cash flow (dilution-adjusted): 423776.2237762238
Buyback yield (%): 0
Retained earnings: -119795104.8951049
Receivables turnover: -1.8678756476683938
Capitalized R&D asset: 6172.338772338772
ROCI (R&D-adjusted, %): -25.10029389401302
Rule of 40 score: 0
Financial ratios for TIE.V — quarterly report dated 2025-06-30
Total revenue: -272262.7737226277
Gross profit: -326277.3722627737
Operating income: 2194160.583941606
Net income: 2193430.6569343065
Capital expenditures: 0
Operating cash flow: -359854.01459854015
Net tangible assets: 8994160.583941605
Owner earnings: 2193430.6569343065
Return on net tangible assets (%): 24.387274793053077
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.635036496350365
P/E ratio: 0.5280539550748752
Shares outstanding: 7295642
Book value: 8994160.583941605
P/B ratio: 0.5151118763187795
Market cap (USD): 4632998.934306569
Debt to equity: 0
Current ratio: 7.374547335747543
Quick ratio: 7.374547335747543
Free cash flow (dilution-adjusted): -359854.01459854015
Buyback yield (%): 0
Retained earnings: -122848175.18248174
Receivables turnover: -0.966321243523316
Capitalized R&D asset: 2076.923076923077
ROCI (R&D-adjusted, %): 24.366438526478852
Rule of 40 score: 0
Financial ratios for TIE.V — annual report dated 2025-09-30
Total revenue: -761870.5035971224
Gross profit: -993525.1798561151
Operating income: -4327338.129496403
Net income: -4317985.611510792
Capital expenditures: 0
Operating cash flow: -305035.9712230216
Depreciation & amortization: 0
Net tangible assets: 11735251.798561152
Owner earnings: -4317985.611510792
Return on net tangible assets (%): -36.79499754781756
Buffett classification: The Gruesome
Stock price: 0.6330935251798562
Shares outstanding: 7295642
Book value: 11735251.798561152
P/B ratio: 0.3935853948013732
Market cap (USD): 4618823.712230217
Debt to equity: 0
Current ratio: 12.601706970128022
Quick ratio: 12.601706970128022
Free cash flow (dilution-adjusted): -305035.9712230216
Buyback yield (%): 0
Retained earnings: -118389928.05755396
Receivables turnover: -2.576642335766423
Capitalized R&D asset: 12903.703703703704
ROCI (R&D-adjusted, %): -36.888836564576835
Rosenberg metric: -5.971499723298291
Rule of 40 score: 0
Financial ratios for TIE.V — quarterly report dated 2025-09-30
Total revenue: 50359.71223021583
Gross profit: -2877.697841726619
Operating income: 2690647.482014389
Net income: 2690647.482014389
Capital expenditures: 0
Operating cash flow: -405755.39568345324
Net tangible assets: 11735251.798561152
Owner earnings: 2690647.482014389
Return on net tangible assets (%): 22.927905836194213
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.6330935251798562
P/E ratio: 0.42915541176470584
Shares outstanding: 7295642
Book value: 11735251.798561152
P/B ratio: 0.3935853948013732
Market cap (USD): 4618823.712230217
Debt to equity: 0
Current ratio: 12.601706970128022
Quick ratio: 12.601706970128022
COGS to revenue (%): 105.71428571428572
R&D to revenue (%): 0
SG&A to revenue (%): 160
Free cash flow (dilution-adjusted): -405755.39568345324
Buyback yield (%): 0
Retained earnings: -118389928.05755396
Receivables turnover: 0.170316301703163
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.927905836194213
FCF margin (%): -805.7142857142857
Rule of 40 score: -805.7142857142857
Financial ratios for TIE.V — quarterly report dated 2025-12-31
Total revenue: 49635.03649635036
Operating income: -1840145.9854014597
Net income: -1840145.9854014597
Capital expenditures: 0
Operating cash flow: -310218.9781021898
Net tangible assets: 10066423.357664233
Owner earnings: -1840145.9854014597
Return on net tangible assets (%): -18.280037705750125
Buffett classification: The Gruesome
Stock price: 0.510948905109489
P/E ratio: 2.2909398197956237
Shares outstanding: 7295642
Book value: 10066423.357664233
P/B ratio: 0.37031030382133273
Market cap (USD): 3727700.2919708025
Debt to equity: 0
Current ratio: 7.1539491298527444
Quick ratio: 7.1539491298527444
COGS to revenue (%): 0
R&D to revenue (%): 0
SG&A to revenue (%): 348.5294117647059
Free cash flow (dilution-adjusted): -310218.9781021898
Buyback yield (%): 0
Retained earnings: -121958394.16058393
Receivables turnover: 0.2207792207792208
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.280037705750125
FCF margin (%): -625.0000000000001
Revenue growth (%): -1.4389989572471504
Rule of 40 score: -626.4389989572472
Financial ratios for TNE.L — annual report dated 2022-12-31
Total revenue: 0
Operating income: -322399.9277108434
Net income: -322399.9277108434
Capital expenditures: 0
Operating cash flow: -303250.7951807229
Net tangible assets: 792074.4096385543
Owner earnings: -322399.9277108434
Return on net tangible assets (%): -40.70323744684082
Buffett classification: The Gruesome
Stock price: 0.0015662650602409638
Shares outstanding: 159263550
Book value: 792074.4096385541
P/B ratio: 0.3149311866403692
Market cap (USD): 249448.93373493975
Debt to equity: 0
Current ratio: 7.853037544312896
Quick ratio: 7.853037544312896
Free cash flow (dilution-adjusted): -303250.7951807229
Buyback yield (%): 0
Retained earnings: -363617.32530120487
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -40.70323744684083
Rule of 40 score: 0
Financial ratios for TNE.L — annual report dated 2023-12-31
Total revenue: 0
Operating income: -73993.62025316455
Net income: -73993.62025316455
Capital expenditures: 0
Operating cash flow: -129828.37974683543
Net tangible assets: 775836.7848101266
Owner earnings: -73993.62025316455
Return on net tangible assets (%): -9.537266304184492
Buffett classification: The Gruesome
Stock price: 0.0007594936708860758
Shares outstanding: 159263550
Book value: 775836.7848101265
P/B ratio: 0.15590864031724277
Market cap (USD): 120959.65822784808
Debt to equity: 0
Current ratio: 12.667762415215597
Quick ratio: 12.667762415215597
Free cash flow (dilution-adjusted): -129828.37974683543
Buyback yield (%): 0
Retained earnings: -464124.9873417721
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.537266304184493
Rule of 40 score: 0
Financial ratios for TNE.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 44236.962499999994
Buffett classification: The Gruesome
Stock price: 0.0007499999999999999
Shares outstanding: 159263550
Book value: 44236.975000000035
P/B ratio: 2.700177001252909
Market cap (USD): 119447.66249999999
Debt to equity: 0
Current ratio: 1.1067576417333511
Quick ratio: 1.1067576417333511
Buyback yield (%): 0
Retained earnings: -1236989.1125
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TNE.L — annual report dated 2024-12-31
Total revenue: 0
Operating income: -757418.65
Net income: -757417.1499999999
Capital expenditures: 0
Operating cash flow: -362905.025
Net tangible assets: 44236.962499999994
Owner earnings: -757417.1499999999
Return on net tangible assets (%): -1712.1816399577615
Buffett classification: The Gruesome
Stock price: 0.0007499999999999999
Shares outstanding: 159263550
Book value: 44236.975000000035
P/B ratio: 2.700177001252909
Market cap (USD): 119447.66249999999
Debt to equity: 0
Current ratio: 1.1067576417333511
Quick ratio: 1.1067576417333511
Free cash flow (dilution-adjusted): -362905.025
Buyback yield (%): 0
Retained earnings: -1236989.1125
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1712.1264917020749
Rule of 40 score: 0
Financial ratios for UCL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.59
Shares outstanding: 25884952
Market cap (USD): 170581833.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UCL — annual report dated 2022-12-31
Total revenue: 9173427.471116817
Gross profit: 4176379.974326059
Operating income: -512451.86136071885
Net income: -2548523.7483953787
Capital expenditures: 18613.607188703467
Operating cash flow: 565340.1797175866
Depreciation & amortization: 125930.68035943517
Net tangible assets: 1089730.4236200256
Owner earnings: -2441206.675224647
Return on net tangible assets (%): -224.0193191188597
Buffett classification: The Gruesome
Stock price: 3.34
Shares outstanding: 25884952
Book value: 1192682.9268292682
P/B ratio: 72.48845249243354
Market cap (USD): 86455739.67999999
Debt to equity: 0.32935098482402325
Current ratio: 1.1346634100826039
Quick ratio: 1.0352095282526963
Interest coverage ratio: -9.052154195011338
COGS to revenue (%): 54.473069226571134
R&D to revenue (%): 11.79664432347714
SG&A to revenue (%): 40.624956269853485
Free cash flow (dilution-adjusted): 113093.70988446724
Buyback yield (%): 0
Retained earnings: -29445057.766367137
Inventory turnover: 10.741445916114792
Receivables turnover: 9.690941144561975
Capitalized R&D asset: 1082156.6110397945
ROCI (R&D-adjusted, %): 9.082287308228729
FCF margin (%): 1.232840290508109
Rule of 40 score: 1.232840290508109
Financial ratios for UCL — annual report dated 2023-12-31
Total revenue: 10957234.314980794
Gross profit: 5373239.436619719
Operating income: 666709.3469910371
Net income: 359923.1754161332
Capital expenditures: 236619.71830985916
Operating cash flow: 833162.6120358515
Depreciation & amortization: 143533.93085787454
Net tangible assets: 1971959.0268886045
Owner earnings: 266837.38796414854
Return on net tangible assets (%): 13.531588857866373
Capex to operating income (%): 35.49068561551758
Buffett classification: The Good
Stock price: 1.75
P/E ratio: 125.85648575595872
Shares outstanding: 25884952
Book value: 2055441.7413572343
P/B ratio: 22.038409111069583
Market cap (USD): 45298666
Debt to equity: 0.47748084470192487
Current ratio: 1.2528947166628326
Quick ratio: 1.1970963371929553
Effective tax rate (%): 2.7733755942947704
Interest coverage ratio: 39.150375939849624
COGS to revenue (%): 50.961718238758536
R&D to revenue (%): 7.544171262970928
SG&A to revenue (%): 36.71823875853043
Free cash flow (dilution-adjusted): 144430.2176696543
Buyback yield (%): 0
Retained earnings: -29009731.113956466
Inventory turnover: 19.977553825011455
Receivables turnover: 8.153978084802286
Capitalized R&D asset: 1551677.4518038328
ROCI (R&D-adjusted, %): 22.612153727723186
Rosenberg metric: 1.1059946869831088
FCF margin (%): 1.318126577545106
Revenue growth (%): 19.44536924154487
Rule of 40 score: 20.763495819089975
Financial ratios for UCL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.37
Shares outstanding: 25884952
Market cap (USD): 35462384.24
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UCL — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.1
Shares outstanding: 25884952
Market cap (USD): 54358399.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UCL — annual report dated 2024-12-31
Total revenue: 11808634.020618558
Gross profit: 5716623.711340207
Operating income: 417268.0412371134
Net income: 587371.1340206186
Capital expenditures: 484278.3505154639
Operating cash flow: 1183762.8865979381
Depreciation & amortization: 300000
Net tangible assets: 2721134.020618557
Owner earnings: 403092.7835051547
Return on net tangible assets (%): 14.81341163099072
Capex to operating income (%): 116.05929586164298
Buffett classification: The Gruesome
Stock price: 2.1
P/E ratio: 92.54523426766126
Shares outstanding: 25884952
Book value: 2786469.072164949
P/B ratio: 19.507985838782776
Market cap (USD): 54358399.2
Debt to equity: 0.45770707117421255
Current ratio: 1.3171807211777815
Quick ratio: 1.286076669590574
Effective tax rate (%): 1.539855072463768
Interest coverage ratio: 16.520408163265305
COGS to revenue (%): 51.58945817646096
R&D to revenue (%): 6.763791127844164
SG&A to revenue (%): 39.147705571015436
Free cash flow (dilution-adjusted): 508634.02061855665
Buyback yield (%): 0
Retained earnings: -28609278.350515466
Inventory turnover: 36.03201219512195
Receivables turnover: 8.183888541573637
Capitalized R&D asset: 1709666.8118621218
ROCI (R&D-adjusted, %): 6.745037569614233
Rosenberg metric: 0.41540136083751733
FCF margin (%): 4.307306160309925
Revenue growth (%): 7.770206250620429
Rule of 40 score: 12.077512410930353
Financial ratios for UCL — quarterly report dated 2025-03-31
Total revenue: 2409897.1722365036
Gross profit: 1245501.2853470438
Operating income: -69665.80976863753
Net income: -78920.30848329049
Capital expenditures: 0
Operating cash flow: 30334.190231362467
Net tangible assets: 2680205.6555269924
Owner earnings: -78920.30848329049
Return on net tangible assets (%): -2.9445616727412234
Buffett classification: The Gruesome
Stock price: 1.24
Shares outstanding: 25884952
Book value: 2741131.1053984575
P/B ratio: 11.70952400517678
Market cap (USD): 32097340.48
Debt to equity: 0.4863077933039482
Current ratio: 1.3354218880534672
Quick ratio: 1.2779743476337904
Interest coverage ratio: -9.508771929824562
COGS to revenue (%): 48.3172435863246
R&D to revenue (%): 7.461731292335591
SG&A to revenue (%): 47.111845965118135
Free cash flow (dilution-adjusted): 30334.190231362467
Buyback yield (%): 0
Retained earnings: -28614652.9562982
Inventory turnover: 3.8746792130025662
Receivables turnover: 2.4441402685438662
Capitalized R&D asset: 179820.05141388174
ROCI (R&D-adjusted, %): 1.6666666666666663
FCF margin (%): 1.258733799135954
Rule of 40 score: 1.258733799135954
Financial ratios for UCL — quarterly report dated 2025-06-30
Total revenue: 2468280.25477707
Gross profit: 1303057.3248407643
Operating income: -25859.87261146497
Net income: 86369.42675159236
Capital expenditures: 0
Operating cash flow: -111719.74522292994
Net tangible assets: 2796687.8980891723
Owner earnings: 86369.42675159236
Return on net tangible assets (%): 3.0882754851052194
Buffett classification: The Gruesome
Stock price: 1.93
P/E ratio: 6706.559831730071
Shares outstanding: 25884952
Book value: 2860382.165605096
P/B ratio: 17.46548344508773
Market cap (USD): 49957957.36
Debt to equity: 0.4426382827113209
Current ratio: 1.3733512077179038
Quick ratio: 1.264548871280492
Effective tax rate (%): 12.179487179487179
Interest coverage ratio: -3.4406779661016946
COGS to revenue (%): 47.20788604459125
R&D to revenue (%): 8.082163501238645
SG&A to revenue (%): 45.75763831544178
Free cash flow (dilution-adjusted): -111719.74522292994
Buyback yield (%): 0
Retained earnings: -28273121.01910828
Inventory turnover: 2.012541254125413
Receivables turnover: 2.8064889918887603
Capitalized R&D asset: 319969.88030717336
ROCI (R&D-adjusted, %): 1.4547229944951283
Rosenberg metric: 0.3200757593003185
FCF margin (%): -4.526218001651527
Revenue growth (%): 2.422637912238562
Rule of 40 score: -2.103580089412965
Financial ratios for UCL — quarterly report dated 2025-09-30
Total revenue: 2719023.1362467865
Gross profit: 1456041.1311053985
Operating income: 15424.164524421592
Net income: 1196143.9588688945
Capital expenditures: 0
Operating cash flow: -115424.16452442159
Net tangible assets: 4010411.3110539843
Owner earnings: 1196143.9588688945
Return on net tangible assets (%): 29.825967116438573
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.17
P/E ratio: 46.668884116219616
Shares outstanding: 25884952
Book value: 4078791.77377892
P/B ratio: 13.77131978177922
Market cap (USD): 56170345.839999996
Debt to equity: 0.29092742570825325
Current ratio: 1.679341864716636
Quick ratio: 1.5545312091930006
Effective tax rate (%): -0.7798115455431605
Interest coverage ratio: 5.7142857142857135
COGS to revenue (%): 46.44984400113454
R&D to revenue (%): 6.986858277394346
SG&A to revenue (%): 45.996029119788226
Free cash flow (dilution-adjusted): -115424.16452442159
Buyback yield (%): 0
Retained earnings: -27331362.467866324
Inventory turnover: 2.056078677547604
Receivables turnover: 3.319836785938481
Capitalized R&D asset: 382973.5087518216
ROCI (R&D-adjusted, %): 0.33948085555535823
Rosenberg metric: 0.7668728474951333
FCF margin (%): -4.245060035927012
Revenue growth (%): 10.158606624366604
Rule of 40 score: 5.9135465884395915
Financial ratios for UCL — annual report dated 2025-12-31
Total revenue: 10469023.136246786
Gross profit: 5486246.786632391
Operating income: 250128.53470437016
Net income: 809897.1722365038
Capital expenditures: 89845.75835475579
Operating cash flow: 412339.33161953726
Depreciation & amortization: 361053.98457583546
Net tangible assets: 3637146.529562982
Owner earnings: 1081105.3984575835
Return on net tangible assets (%): 29.72399901049581
Capex to operating income (%): 35.91983556012334
Buffett classification: The Good
Stock price: 1.64
P/E ratio: 52.41569267709887
Shares outstanding: 25884952
Book value: 3702827.7634961437
P/B ratio: 11.464568160177729
Market cap (USD): 42451321.28
Debt to equity: 0.31248264371008055
Current ratio: 1.6662224277205102
Quick ratio: 1.547148257948704
Effective tax rate (%): 19.45649400357234
Interest coverage ratio: 9.928571428571429
COGS to revenue (%): 47.59542781372393
R&D to revenue (%): 5.976746184729095
SG&A to revenue (%): 44.89066777983769
Free cash flow (dilution-adjusted): 143830.33419023134
Buyback yield (%): 0
Retained earnings: -27725835.475578405
Inventory turnover: 8.854728186386478
Receivables turnover: 10.871462893753336
Capitalized R&D asset: 1433632.2712065466
ROCI (R&D-adjusted, %): 2.3125895409351584
Rosenberg metric: -0.28843577536828846
FCF margin (%): 1.373865854706626
Revenue growth (%): -11.344334001991546
Rule of 40 score: -9.97046814728492
Financial ratios for UCL — quarterly report dated 2025-12-31
Total revenue: 2849614.395886889
Gross profit: 1469922.8791773778
Operating income: 330462.72493573267
Net income: -394473.00771208224
Capital expenditures: 0
Operating cash flow: 610154.2416452442
Net tangible assets: 3637146.529562982
Owner earnings: -394473.00771208224
Return on net tangible assets (%): -10.845672686150476
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.64
P/E ratio: 52.4660342564015
Shares outstanding: 25884952
Book value: 3702827.7634961437
P/B ratio: 11.464568160177729
Market cap (USD): 42451321.28
Debt to equity: 0.31248264371008055
Current ratio: 1.6662224277205102
Quick ratio: 1.547148257948704
Interest coverage ratio: 43.57627118644068
COGS to revenue (%): 48.416779431664416
R&D to revenue (%): 1.9170049616599005
SG&A to revenue (%): 41.19981957600361
Free cash flow (dilution-adjusted): 475706.940874036
Buyback yield (%): 0
Retained earnings: -27725835.475578405
Inventory turnover: 2.4518044769301053
Receivables turnover: 2.9591564335290976
Capitalized R&D asset: 247741.8728406988
ROCI (R&D-adjusted, %): 5.590643259805262
Rosenberg metric: 0.07307171853856474
FCF margin (%): 16.693730266125396
Revenue growth (%): 4.802874160915191
Rule of 40 score: 21.496604427040587
Financial ratios for UGROCAP.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.1943821706448636
Shares outstanding: 152815503
Market cap (USD): 335335615.1813267
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UGROCAP.NS — annual report dated 2023-03-31
Total revenue: 59435968.33130329
Gross profit: 22246394.640682098
Operating income: 27420036.540803898
Net income: 4844872.107186358
Capital expenditures: 162436.05359317907
Operating cash flow: -148651425.09135202
Depreciation & amortization: 2148282.582216809
Net tangible assets: 114083775.88306944
Owner earnings: 6830718.635809988
Return on net tangible assets (%): 5.987458411975386
Capex to operating income (%): 0.5923991142442758
Buffett classification: The Great
Stock price: 1.7667478684531062
P/E ratio: 55.726231408951044
Shares outstanding: 152815503
Book value: 119859086.47990257
P/B ratio: 2.252532303732428
Market cap (USD): 269986464.1918393
Debt to equity: 3.1999965245424717
Current ratio: 1.049600567731547
Quick ratio: 1.049600567731547
Effective tax rate (%): 52.550209714130304
Interest coverage ratio: 1.8789562508763846
COGS to revenue (%): 62.57082156602885
SG&A to revenue (%): 7.794957592619044
Free cash flow (dilution-adjusted): -153945152.2533496
Buyback yield (%): 1.1257207110569825
Retained earnings: 13850925.70036541
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.369048500654449
FCF margin (%): -259.01008526561
Rule of 40 score: -259.01008526561
Financial ratios for UGROCAP.NS — annual report dated 2024-03-31
Total revenue: 84777035.61578126
Gross profit: 27602818.083703082
Operating income: 43627185.513850585
Net income: 14311644.082024224
Capital expenditures: 327952.9919654635
Operating cash flow: -184068269.57668784
Depreciation & amortization: 4236838.94951433
Net tangible assets: 163179398.00935364
Owner earnings: 18220530.03957309
Return on net tangible assets (%): 11.165950029138278
Capex to operating income (%): 0.7517170500520743
Buffett classification: The Great
Stock price: 2.634956813819578
P/E ratio: 28.13528959910831
Shares outstanding: 152815503
Book value: 172486113.44285893
P/B ratio: 2.3344618465214
Market cap (USD): 402662250.88711613
Debt to equity: 3.2351009485305386
Current ratio: 1.4560540154372914
Quick ratio: 1.4560540154372914
Effective tax rate (%): 33.23834696874345
Interest coverage ratio: 2.6748201259008413
COGS to revenue (%): 67.44068970658275
SG&A to revenue (%): 7.798946949575483
Free cash flow (dilution-adjusted): -189451960.66674662
Buyback yield (%): 0
Retained earnings: 25100071.95107327
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.162972197297746
FCF margin (%): -223.47084831482368
Revenue growth (%): 42.63591221938842
Rule of 40 score: -180.83493609543527
Financial ratios for UGROCAP.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 224259448.16053513
Buffett classification: The Gruesome
Stock price: 3.0115862398471096
Shares outstanding: 152815503
Book value: 233852723.36359298
P/B ratio: 1.9679782191570703
Market cap (USD): 460217066.0701147
Debt to equity: 2.712321439972622
Current ratio: 191.9378552136667
Quick ratio: 191.9378552136667
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UGROCAP.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.6920386991490846
Shares outstanding: 152815503
Market cap (USD): 411385247.905933
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UGROCAP.NS — quarterly report dated 2025-03-31
Total revenue: 27657388.356324524
Gross profit: 26416074.351180732
Operating income: 30897205.985503856
Net income: 4740191.723170446
Capital expenditures: 0
Depreciation & amortization: 1547322.8898760811
Net tangible assets: 230557481.87982228
Owner earnings: 6287514.613046527
Return on net tangible assets (%): 2.7270919866846413
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.9240284747345082
P/E ratio: 15.50682948727981
Shares outstanding: 152815503
Book value: 239231868.13186812
P/B ratio: 1.229022627498807
Market cap (USD): 294021379.1528767
Debt to equity: 3.3738034413196236
Current ratio: 1.400812587768638
Quick ratio: 1.400812587768638
Effective tax rate (%): 29.12497815067296
COGS to revenue (%): 4.488182286596616
Buyback yield (%): 0
Retained earnings: 37896282.44096329
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.101295686273731
Rule of 40 score: 0
Financial ratios for UGROCAP.NS — annual report dated 2025-03-31
Total revenue: 112674982.46434416
Gross profit: 38092506.429740466
Operating income: 57335842.88052373
Net income: 16826034.60369418
Capital expenditures: 3033434.650455927
Operating cash flow: -289225005.8452186
Depreciation & amortization: 5422597.6151508065
Net tangible assets: 230557481.87982228
Owner earnings: 19215197.568389058
Return on net tangible assets (%): 8.334232926088665
Capex to operating income (%): 5.290642812693955
Buffett classification: The Great
Stock price: 1.9240284747345082
P/E ratio: 17.474193182053952
Shares outstanding: 152815503
Book value: 239231868.13186812
P/B ratio: 1.229022627498807
Market cap (USD): 294021379.1528767
Debt to equity: 3.3738034413196236
Current ratio: 1.400812587768638
Quick ratio: 1.400812587768638
Effective tax rate (%): 29.13955180599988
Interest coverage ratio: 2.3428488173517183
COGS to revenue (%): 66.19257833761387
SG&A to revenue (%): 5.406237958095573
Free cash flow (dilution-adjusted): -295915443.0675707
Buyback yield (%): 0
Retained earnings: 37896282.44096329
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.6107608301244785
FCF margin (%): -262.62745872732904
Revenue growth (%): 32.90743377133334
Rule of 40 score: -229.7200249559957
Financial ratios for UGROCAP.NS — quarterly report dated 2025-06-30
Total revenue: 37700152.11794992
Gross profit: 6542171.776269601
Operating income: 10184249.941493098
Net income: 3993728.05991107
Capital expenditures: 0
Depreciation & amortization: 1495190.7325064358
Owner earnings: 5488918.792417506
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.020243388719869
P/E ratio: 35.34776106229894
Shares outstanding: 152815503
Market cap (USD): 308724509.6296513
Effective tax rate (%): 29.144029213991658
COGS to revenue (%): 82.64682923346955
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 36.31132351413389
Rule of 40 score: 36.31132351413389
Financial ratios for UGROCAP.NS — quarterly report dated 2025-09-30
Total revenue: 39339379.93235625
Gross profit: 7112514.092446448
Operating income: 10570980.83427283
Net income: 4882886.133032694
Capital expenditures: 0
Depreciation & amortization: 1594103.7204058624
Net tangible assets: 268947824.1262683
Owner earnings: 6476989.853438557
Return on net tangible assets (%): 2.4082700332231264
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.9259301014656145
P/E ratio: 21.613877660547274
Shares outstanding: 152815503
Book value: 277663134.1600902
P/B ratio: 1.0599605816904003
Market cap (USD): 294311977.19830894
Debt to equity: 3.172850883034116
Current ratio: 234.67048831026662
Quick ratio: 234.67048831026662
Effective tax rate (%): 29.119807281915662
COGS to revenue (%): 81.92011642106114
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8732168475497784
Revenue growth (%): 4.348066844074777
Rule of 40 score: 4.348066844074777
Financial ratios for UGROCAP.NS — quarterly report dated 2025-12-31
Total revenue: 39510861.08945082
Gross profit: 3421009.245850507
Operating income: -4761880.360922357
Net income: 5153737.328728974
Capital expenditures: 0
Depreciation & amortization: 1603508.967361034
Owner earnings: 6757246.296090008
Buffett classification: The Gruesome
Stock price: 1.9486465411607443
P/E ratio: 15.864399739123114
Shares outstanding: 152815503
Market cap (USD): 297783401.35668933
Effective tax rate (%): 26.54817660787146
COGS to revenue (%): 91.34159785051128
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 0.4359020335079721
Rule of 40 score: 0.4359020335079721
Financial ratios for XAIR — annual report dated 2022-03-31
Total revenue: 0
Gross profit: 0
Operating income: -30210000
Net income: -43177000
Capital expenditures: 1449000
Operating cash flow: -23134000
Depreciation & amortization: 588000
Net tangible assets: 70867000
Owner earnings: -44038000
Return on net tangible assets (%): -62.14175850536922
Buffett classification: The Gruesome
Stock price: 2672
Shares outstanding: 720531
Book value: 78209000
P/B ratio: 24.61684501783682
Market cap (USD): 1925258832
Debt to equity: 0.04458566149675869
Current ratio: 8.676717699775953
Quick ratio: 8.644044062733384
Interest coverage ratio: -38.980645161290326
Free cash flow (dilution-adjusted): -32414000
Buyback yield (%): 0
Retained earnings: -123639000
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 11802000
ROCI (R&D-adjusted, %): -22.277617684890664
Rule of 40 score: 0
Financial ratios for XAIR — annual report dated 2023-03-31
Total revenue: 0
Gross profit: -555000
Operating income: -52059000
Net income: -55816000
Capital expenditures: 3877000
Operating cash flow: -33009000
Depreciation & amortization: 1170000
Net tangible assets: 36283000
Owner earnings: -58523000
Return on net tangible assets (%): -161.29592371082876
Buffett classification: The Gruesome
Stock price: 2700
Shares outstanding: 720531
Book value: 42028000
P/B ratio: 46.288990672884744
Market cap (USD): 1945433700
Debt to equity: 0.08546683163605216
Current ratio: 3.0035389282103133
Quick ratio: 2.9464610717896864
Interest coverage ratio: -1735.3
Free cash flow (dilution-adjusted): -56444000
Buyback yield (%): 0
Retained earnings: -179455000
Inventory turnover: 0.491585473870682
Receivables turnover: 0
Capitalized R&D asset: 24717340
ROCI (R&D-adjusted, %): -60.77969584774239
Rosenberg metric: -0.04702592780884596
Rule of 40 score: 0